A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase

J Comput Aided Mol Des. 1996 Jun;10(3):233-46. doi: 10.1007/BF00355045.

Abstract

A molecular dynamics/energy-minimisation protocol has been used to analyse the structural and energetic effects of functional group substitution on the binding of a series of C4-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid inhibitors to influenza virus sialidase. Based on the crystal structure of sialidase, a conformational searching protocol, incorporating multiple randomisation steps in a molecular dynamics simulation was used to generate a range of minimum-energy structures. The calculations were useful for predicting the number, location, and orientation of structural water molecules within protein-ligand complexes. Relative binding energies were calculated for the series of complexes using several empirical molecular modelling approaches. Energies were computed using molecular-mechanics-derived interactions as the sum of pairwise atomic nonbonded energies, and in a more rigorous manner including solvation effects as the change in total electrostatic energy of complexation, using a continuum-electrostatics (CE) approach. The CE approach exhibited the superior correlation with observed affinities. Both methods showed definite trends in observed and calculated binding affinities; in both cases inhibitors with a positively charged C4 substituent formed the tightest binding to the enzyme, as observed experimentally.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Computer Simulation
  • Enzyme Inhibitors / chemistry*
  • Kinetics
  • Ligands
  • Models, Molecular
  • N-Acetylneuraminic Acid / chemistry*
  • Neuraminidase / antagonists & inhibitors*
  • Orthomyxoviridae / enzymology*
  • Protein Binding
  • Thermodynamics
  • Viral Proteins / chemistry

Substances

  • Enzyme Inhibitors
  • Ligands
  • Viral Proteins
  • Neuraminidase
  • N-Acetylneuraminic Acid